Staphylococcal toxic shock syndrome (TSS) is an acute, multisystem febrile illness caused by Staphylococcus aureus. A similar illness caused by group A streptococcal infections is discussed in Chapter 34.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Todd, J. K., Fishaut, M., Kapral, F., and Welch, T., Toxic-shock syndrome associated with phage-group-I staphylococci, Lancet 2:1116–1118 (1978).
Aranow, H., Jr., and Wood, W. B., Staphylococcal infection simulating scarlet fever, J. Am. Med. Assoc. 119:1491–1495 (1942).
Stevens, F. A., The occurrence of Staphylococcus aureus infection with a scarlatiniform rash, J. Am. Med. Assoc. 88:1957–1958 (1927).
Everett, E. D., Mucocutaneous lymph node syndrome (Kawasakidisease) in adults, J. Am. Med. Assoc. 242:542–543 (1979).
Davis, J. P., Chesney, P. J., Wand, P. J., LaVenture, M., and the Investigation and Laboratory Team, Toxic-shock syndrome: Epidemiologic features, recurrence, risk factors, and prevention, N. Engl. J. Med. 303:1429–1435 (1980).
Shands, K. N., Schmid, G. P., Dan, B. B., Blum, D., Guidotti, R. J., Hargrett, N. T., Anderson, R. L., Hill, D. L., Broome, C. V., Band, J. D., and Fraser, D. W., Toxic-shock syndrome in menstruating women: Its association with tampon use and Staphylococcus aureus and the clinical features in 52 cases, N. Engl. J. Med. 303:1436–1442 (1980).
Centers for Disease Control, Follow-up on toxic-shock syndrome—United States, Morb. Mortal. Wkly. Rep. 29:297–299(1980).
Centers for Disease Control, Toxic-shock syndrome—United States, Morb. Mortal. Wkly. Rep. 29:229–230 (1980).
Reingold, A. L., Epidemiology of toxic-shock syndrome, United States, 1960–1984, Centers for Disease Control, CDC Surveillance Summaries 33:(3SS):19SS–22SS (1984).
Reingold, A. L., Hargrett, N. T., Shands, K. N., Dan, B. B., Schmid, G. P., Strickland, B. Y., and Broome, C. V., Toxic shock syndrome surveillance in the United States, 1980 to 1981, Ann. Intern. Med. 92(Part 2):875–880 (1982).
Petitti, D. B., Reingold, A. L., and Chin, J., The incidence of toxic shock syndrome in northern California, 1972 through 1983, J. Am. Med. Assoc. 255:368–372 (1986).
Todd, J. K., Wiesenthal, A. M., Ressman, M., Castan, S. A., and Hopkins, R. S., Toxic shock syndrome. II. Estimated occurrence in Colorado as influenced by case ascertainment methods, Am. J. Epidemiol. 122:857–867 (1985).
Berkley, S. F., Hightower, A. W., Broome, C. V., and Reingold, A. L., The relationship of tampon characteristics to menstrual toxic shock syndrome, J. Am. Med. Assoc. 258:917–920 (1987).
Lanes, S. F., and Rothman, K. J., Tampon absorbency, composition and oxygen content and risk of toxic shock syndrome, J. Clin. Epidemiol. 43:1379–1385 (1990).
Osterholm, M. T., Davis, J. P., and Gibson, R. W., Tri-state toxic-shock syndrome study. I. Epidemiologic findings, J. Infect. Dis. 145:431–440 (1982).
Schlech, W. F., Shands, K. N., Reingold, A. L., Dan, B. B., Schmid, G. P., Hargrett, N. T., Hightower, A., Herwaldt, L. A., Neill, M. A., Band, J. D., and Bennett, J. V., Risk factors for the development of toxic shock syndrome: Association with a tampon brand, J. Am. Med. Assoc. 248:835–839 (1982).
Petitti, D. B., and Reingold, A. L., Update through 1985 on the incidence of toxic shock syndrome among members of a prepaid health plan, Rev. Infect. Dis. 11(Suppl. 1):22–27 (1989).
Reingold, A. L., Broome, C. V., Gaventa, S., Hightower, A. W., and the TSS Study Group, Risk factors for menstrual toxic shock syndrome: Results of a multistate case—control study, Rev. Infect. Dis. 11(Suppl. 1):35–42 (1989).
Markowitz, L. E., Hightower, A. W., Broome, C. V., and Reingold, A. L., Toxic shock syndrome. Evaluation of national surveillance data using a hospital discharge survey, J. Am. Med. Assoc. 258:75–78 (1987).
Linnemann, C. C., Jr., and Knarr, D., Increasing incidence of toxic shock syndrome in the 1970s, Am. J. Public Health 76:566–567 (1986).
Petitti, D. B., and Reingold, A. L., Recent trends in the incidence of toxic shock syndrome in Northern California, Am. J. Public Health 81:1209–1211 (1991).
Jacobson, J. A., Kasworm, E. M., Crass, B. A., and Bergdoll, M. S., Nasal carriage of toxigenic Staphylococcus aureus and prevalence of serum antibody to toxic-shock-syndrome toxin 1 in Utah, J. Infect. Dis. 153:356–359 (1986).
Lansdell, L. W., Taplin, D., and Aldrich, T. E., Recovery of Staphylococcus aureus from multiple body sites in menstruating women, J. Clin. Microbiol. 20:307–310 (1984).
Martin, R. R., Buttram, V., Besch, P., Kirkland, J. J., and Petty, G. P., Nasal and vaginal Staphylococcus aureus in young women: Quantitative studies, Ann. Intern. Med. 96(Part 2):951–953 (1982).
Ritz, H. L., Kirkland, J. J., Bond, G. G., Warner, E. K., and Petty, G. P., Association of high levels of serum antibody to staphylococcal toxic shock antigen with nasal carriage of toxic shock antigen-producing strains of Staphylococcus aureus, Infect. Immun. 43:954–958 (1984).
Schlievert, P. M., Osterholm, M. T., Kelly, J. A., and Nishimura, R. D., Toxin and enzyme characterization of Staphylococcus aureus isolates from patients with and without toxic shock syndrome, Ann. Intern. Med. 96(Part 2):937–940 (1982).
Bonventre, P. F., Linnemann, C., Weckbach, L. S., Staneck, J. L., Buncher, C. R., Vigdorth, E., Ritz, H., Archer, D., and Smith, B., Antibody responses to toxic-shock-syndrome (TSS) toxin by patients with TSS and by healthy staphylococcal carriers, J. Infect. Dis. 150:662–666 (1984).
Vergeront, J. M., Stolz, S. J., Crass, B. A., Nelson, D. B., Davis, J. P., and Bergdoll, M. S., Prevalence of serum antibody to staphylococcal enterotoxin F among Wisconsin residents: Implications for toxic-shock syndrome, J. Infect. Dis. 148:692–698 (1983).
Reingold, A. L., Dan, B. B., Shands, K. N., and Broome, C. V., Toxic-shock syndrome not associated with menstruation: A review of 54 cases, Lancet 1:1–4 (1982).
Reingold, A. L., Hargrett, N. T., Dan, B. B., Shands, K. N., Strickland, B. Y., and Broome, C. V., Nonmenstrual toxic shock syndrome: A review of 130 cases, Ann. Intern. Med. 96(Part 2):871–874 (1982).
Miwa, K., Fukuyama, M., Kunitomo, T., and Igarashi, H., Rapid assay for detection of toxic shock syndrome toxin 1 from human sera, J. Clin. Microbiol. 32:539–542 (1994).
Vergeront, J. M., Evenson, M. L., Crass, B. A., Davis, J. P., Bergdoll, M. S., Wand, P. J., Noble, J. H., and Petersen, G. K., Recovery of staphylococcal enterotoxin F from the breast milk of a woman with toxic-shock syndrome, J. Infect. Dis. 146: 456–459 (1982).
Stolz, S. J., Davis, J. P., Vergeront, J. M., Crass, B. A., Chesney, P. J., Wand, P. J., and Bergdoll, M. S., Development of serum antibody to toxic shock toxin among individuals with toxic shock syndrome in Wisconsin, J. Infect. Dis. 151:883–889 (1985).
Corbishley, C. M., Microbial flora of the vagina and cervix, J. Clin. Pathol. 30:745–748 (1977).
Guinan, M. E., Dan, B. B., Guidotti, R. J., Reingold, A. L., Schmid, G. P., Bettoli, E. J., Lossick, J. G., Shands, K. N., Kramer, M. A., Hargrett, N. T., Anderson, R. L., and Broome, C. V., Vaginal colonization with Staphylococcus aureus in healthy women: A review of four studies, Ann. Intern. Med. 96(Part 2):944–947 (1982).
Linnemann, C. C., Staneck, J. L., Hornstein, S., Barden, T. P., Rauh, J. L., Bonventre, P. F., Buncher, C. R., and Beiting, A., The epidemiology of genital colonization with Staphylococcus aureus, Ann. Intern. Med. 96(Part 2):940–944 (1982).
Noble, V. S., Jacobson, J. A., and Smith, C. B., The effect of menses and use of catamenial products on cervical carriage of Staphylococcus aureus, Am. J. Obstet. Gynecol. 144:186–189 (1982).
Onderdonk, A. B., Zamarchi, G. R., Walsh, J. A., Mellor, R. D., Munoz, A., and Kass, E. H., Methods for quantitative and qualitative evaluation of vaginal microflora during menstruation, Appl. Environ. Microbiol. 51:333–339 (1986).
Smith, C. B., Noble, V., Bensch, R., Ahlin, P. A., Jacobson, J. A., and Latham, R. H., Bacterial flora of the vagina during the menstrual cycle: Findings in users of tampons, napkins, and sea sponges, Ann. Intern. Med. 96(Part 2):948–951 (1982).
Schlievert, P. M., Shands, K. N., Dan, B. B., Schmid, G. P., and Nishimura, R. D., Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome, J. Infect. Dis. 143:509–516 (1981).
Bergdoll, M. S., Crass, B. A., Reiser, R. F., Robbins, R. N., and Davis, J. P., A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock syndrome Staphylococcus aureus isolates, Lancet 1:1017–1021 (1981).
Altemeier, W. A., Lewis, S. A., Schlievert, P. M., Bergdoll, M. S., Bjornson, H. S., Staneck, J. L., and Crass, B. A., Staphylococcus aureus associated with toxic shock syndrome: Phage typing and toxin capability testing, Ann, Intern. Med. 96(Part 2):978–982 (1982).
Altemeier, W. A., Lewis, S. A., Schlievert, P. M., and Bjornson, H. S., Studies of the staphylococcal causation of toxic shock syndrome, Surg. Gynecol. Obstet. 153:481–485(1981).
Garbe, P. L., Arko, R. J., Reingold, A. L., Graves, L. M., Hayes, P. S., Hightower, A. W., Chandler, F. W., and Broome, C. V., Staphylococcus aureus isolates from patients with nonmenstrual toxic shock syndrome, J. Am. Med. Assoc. 253:2538–2542 (1985).
Kain, K. C., Schulzer, M., and Chow, A. W., Clinical spectrum of nonmenstrual toxic shock syndrome (TSS): Comparison with menstrual TSS by multivariate discriminant analyses, Clin. Infect. Dis. 16:100–106 (1993).
Schlievert, P. M., Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly associated with non-menstrual TSS [letter], Lancet 1:1149–1150 (1986).
Hayes, P. S., Graves, L. M., Feeley, J. C., Hancock, G. A., Cohen, M. L., Reingold, A. L., Broome, C. V., and Hightower, A. W., Production of toxic-shock-associated protein(s) in Staphylococcus aureus strains isolated from 1956 through 1982, J. Clin. Microbiol. 20:43–46 (1984).
Marples, R. R., and Wieneke, A. A., Enterotoxins and toxic-shock syndrome toxin-1 non-enteric staphylococcal disease, Epidemiol. Infect. 110:477–488 (1993).
Barbour, A. G., Vaginal isolates of Staphylococcus aureus associated with toxic shock syndrome, Infect. Immun. 33:442–449 (1981).
Kreiswirth, B. N., Novick, R. P., Schlievert, P. M., and Bergdoll, M., Genetic studies on staphylococcal strains from patients with toxic shock syndrome, Ann. Intern. Med. 96(Part 2):974–977 (1982).
Chow, A. W., Gribble, M. J., and Bartlett, K. H., Characterization of the hemolytic activity of Staphylococcus aureus strains associated with toxic shock syndrome, J. Clin. Microbiol. 17:524–528 (1983).
Chu, M. C., Melish, M. E., and James, J. F., Tryptophan auxotypy associated with Staphylococcus aureus that produce toxic-shock-syndrome toxin, J. Infect. Dis. 151:1157–1158 (1985).
Todd, J. K., Franco-Buff, A., Lawellin, D. W., and Vasil, M. L., Phenotypic distinctiveness of Staphylococcus aureus strains associated with toxic shock syndrome, Infect. Immun. 45:339–344 (1984).
Kreiswirth, B. N., Lofdahl, S., Betley, M. J., O’Reilly, M., Schlievert, P. M., Bergdoll, M. S., and Novick, R. P., The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage [letter], Nature 305:709–712 (1983).
Rasheed, J. K., Arko, R. J., Feeley, J. C., Chandler, F. W., Thornsberry, C., Gibson, R. J., Cohen, M. L., Jeffries, C. D., and Broome, C. V., Acquired ability of Staphylococcus aureus to produce toxic shock-associated protein and resulting illness in a rabbit model, Infect. Immun. 47:598–604 (1985).
Summary of Notifiable Diseases-United States, 2003, Morb. Mortal. Wkly. Rep. 52:26; 30; 73 (2005).
Osterholm, M. T., and Forfang, J. C., Toxic-shock syndrome in Minnesota: Results of an active-passive surveillance system, J. Infect. Dis. 145:458–464 (1982).
Kehrberg, M. W., Latham, R. H., Haslam, B. R., Hightower, A., Tanner, M., Jacobson, J. A., Barbour, A. G., Nobel, V., and Smith, C. B., Risk factors for staphylococcal toxic-shock syndrome, Am. J. Epidemiol. 114:873–879 (1981).
Gaventa, S., Reingold, A. L., Hightower, A. W., Broome, C. V., Schwartz, B., Hoppe, C., Harwell, J., Lefkowitz, L. K., Makintubee, S., Cundiff, D. R., Sitze, S., and the Toxic Shock Syndrome Study Group, Active surveillance for toxic shock syndrome in the United States, 1986, Rev. Infect. Dis. 11:S28–S34 (1989).
Centers for Disease Control, Toxic-shock syndrome—United States, 1970–1982, Morb. Mortal. Wkly. Rep. 31:201–204 (1982).
Reingold, A. L., On the proposed screening definition for toxic shock syndrome by Todd et al. [letter], Am. J. Epidemiol. 122:918–919 (1985).
Faich, G., Pearson, K., Fleming, D., Sobel, S., and Anello, C., Toxic shock syndrome and the vaginal contraceptive sponge, J. Am. Med. Assoc. 255:216–218 (1986).
Finkelstein, J. W., and VonEye, A., Sanitary product use by white, black and Mexican-American women, Am. J. Public Health 105:491–496 (1990).
Gustafson, T. L., Swinger, G. L., Booth, A. L., Hutcheson, R. H., Jr., and Schaffner, W., Survey of tampon use and toxic shock syndrome, Tennessee, 1979 to 1981, Am. J. Obstet. Gynecol. 143:369–374 (1982).
Irwin, C. E., and Millstein, S. G., Emerging patterns of tampon use in the adolescent female: The impact of toxic shock syndrome, Am. J. Public Health 72:464–467 (1982).
Irwin, C. E., and Millstein, S. G., Predictors of tampon use in adolescents after media coverage of toxic shock syndrome, Ann. Intern. Med. 96(Part 2):966–968 (1982).
Arnow, P. M., Chou, T., Weil, D., Crass, B. A., and Bergdoll, M. S., Spread of a toxic-shock syndrome-associated strain of Staphylococcus aureus and measurement of antibodies to staphylococcal enterotoxin F, J. Infect. Dis. 149:103–107 (1984).
Bartlett, P., Reingold, A. L., Graham, D. R., Dan, B. B., Selinger, D. S., Tank, G. W., and Wichterman, K. A., Toxic shock syndrome associated with surgical wound infections, J. Am. Med. Assoc. 247:1448–1450 (1982).
Kreiswirth, B. N., Kravitz, G. R., Schlievert, P. M., and Novick, R. P., Nosocomial transmission of a strain of Staphylococcus aureus causing toxic shock syndrome, Ann. Intern. Med. 105:704–707 (1986).
Helgerson, S. D., and Foster, L. R., Toxic shock syndrome in Oregon: Epidemiologic findings, Ann. Intern. Med. 96(Part 2):909–911 (1982).
Projan, S. J., Brown-Skrobot, S., Schlievert, P. M., Vandenesch, F., and Novick, R. P., Glycerol monolaurate inhibits the production of β-lactamase, toxic shock syndrome toxin-1, and other staphylococcal exoproteins by interfering with signal transduction, J. Bacterial. 176:4204–4209 (1994).
MacDonald, K. L., Osterholm, M. T., Hedberg, C. W., Schrock, C. G., Peterson, G. F., Jentzen, J. M., Leonard, S. A., and Schlievert, P. M., Toxic shock syndrome. A newly recognized complication of influenza and influenzalike illness, J. Am. Med. Assoc. 257:1053–1058 (1987).
Green, S. L., and LaPeter, K. S., Evidence for postpartum toxic-shock syndrome in a mother–infant pair, Am. J. Med. 72:169–172(1982).
Schlievert, P. M., Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C, Infect. Immun. 36:123–128 (1982).
Poindexter, N. J., and Schlievert, P. M., Toxic-shock-syndrome toxin 1-induced proliferation of lymphocytes: Comparison of the mitogenic response of human, murine, and rabbit lymphocytes, J. Infect. Dis. 151:65–72 (1985).
Poindexter, N. J., and Schlievert, P. M., Suppression of immunoglobulin-screening cells from human peripheral blood by toxic-shock-syndrome toxin-1, J. Infect. Dis. 153:772–779 (1986).
Ikejima, T., Dinarello, C. A., Gill, D. M., and Wolff, S. M., Induction of human interleukin-1 by a product of Staphylococcus aureus associated with toxic shock syndrome, J. Clin. Invest. 73:1312–1320 (1984).
Parsonnet, J., Hickman, R. K., Eardley, D. D., and Pier, G. B., Induction of human interleukin-1 by toxic shock syndrome toxin-1, J. Infect. Dis. 151:514–522 (1985).
Kushnaryov, V. M., MacDonald, H. S., Reiser, R., and Bergdoll, M. S., Staphylococcal toxic shock toxin specifically binds to cultured human epithelial cells and is rapidly internalized, Infect. Immun. 45:566–571 (1984).
Schlievert, P. M., Alteration of immune function by staphylococcal pyrogenic exotoxin type C: Possible role in toxic-shock syndrome, J. Infect. Dis. 147:391–398 (1983).
Fujikawa, H., Igarashi, H., Usami, H., Tanaka, S., and Tamura, H., Clearance of endotoxin from blood of rabbits injected with staphylococcal toxic shock syndrome toxin-1, Infect. Immun. 52:134–137 (1986).
Schlievert, P. M., Role of superantigens in human disease, J. Infect. Dis. 167:997–1002 (1993).
Reiser, R. F., Robbins, R. N., Khoe, G. P., and Bergdoll, M. S., Purification and some physicochemical properties of toxic-shock toxin, Biochemistry 22:3907–3912 (1983).
Arko, R. J., Rasheed, J. K., Broome, C. V., Chandler, F. W., and Paris, A. L., A rabbit model of toxic shock syndrome: Clinico-pathological features, J. Infect. 8:205–211 (1984).
Best, G. K., Abney, T. O., Kling, J. M., Kirkland, J. J., and Scott, D. F., Hormonal influence on experimental infections by a toxic shock strain of Staphylococcus aureus, Infect. Immun. 52:331–333 (1986).
Best, G. K., Scott, D. F., Kling, J. M., Crowell, W. F., and Kirkland, J. J., Enhanced susceptibility of male rabbits to infection with a toxic shock strain of Staphylococcus aureus, Infect. Immun. 46:727–732 (1984).
de Azavedo, J. C. S., and Arbuthnott, J. P., Toxicity of staphylococcal toxic shock syndrome toxin-1 in rabbits, Infect. Immun. 46:314–317 (1984).
Parsonnet, J., Gillis, Z. A., Richter, A. G., and Pier, G. B., A rabbit model of toxic shock syndrome that uses a constant, subcutaneous infusion of toxic shock syndrome toxin 1, Infect. Immun. 55:1070–1076 (1987).
Pollack, M., Weinberg, W. G., Hoskins, W. J., O’Brien, W. F., Iannini, P. B., Anderson, S. E., and Schlievert, P. M., Toxinogenic vaginal infections due to Staphylococcus aureus in menstruating rhesus monkeys without toxic-shock syndrome, J. Infect. Dis. 147:963–964 (1983).
Scott, D. F., Kling, J. M., Kirkland, J. J., and Best, G. K., Characterization of Staphylococcus aureus isolates from patients with toxic shock syndrome, using polyethylene infection chambers in rabbits, Infect. Immun. 39:383–387 (1983).
Scott, D. F., Kling, J. M., and Best, G. K., Immunological protection of rabbits infected with Staphylococcus aureus isolates from patients with toxic shock syndrome, Infect. Immun. 53:441–444 (1986).
Tierno, P. M., Jr., Malloy, V., Matias, J. R., and Hanna, B. A., Effects of toxic shock syndrome Staphylococcus aureus, endotoxin and tampons in a mouse model, Clin. Invest. Med. 10:64–70 (1987).
Van Miert, A. S. J. P. A. M., van Duin, C. T. M., and Schotman, A. J. H., Comparative observations of fever and associated clinical hematological and blood biochemical changes after intravenous administration of staphylococcal enterotoxins B and F (toxicshock syndrome toxin-1) in goats, Infect. Immun. 46:354–360 (1984).
Larkin, S. M., Williams, D. N., Osterholm, M. T., Tofte, R. W., and Posalaky, Z., Toxic shock syndrome: Clinical, laboratory, and pathologic findings in nine fatal cases, Ann. Intern. Med. 96(Part 2):858–864 (1982).
Paris, A. L., Herwaldt, L. A., Blum, D., Schmid, G. P., Shands, K. N., and Broome, C. V., Pathologic findings in twelve fatal cases of toxic shock syndrome, Ann. Intern. Med. 96(Part 2):852–857 (1982).
Broome, C. V., Hayes, P. S., Ajello, G. W., Feeley, J. C., Gibson, R. J., Graves, L. M., Hancock, G. A., Anderson, R. L., Highsmith, A. K., Mackel, D. C., Hargrett, N. T., and Reingold, A. L., In vitro studies of interactions between tampons and Staphylococcus aureus, Ann. Intern. Med. 96(Part 2):959–962 (1982).
Schlievert, P. M., Blomster, D. A., and Kelly, J. A., Toxic shock syndrome Staphylococcus aureus: Effect of tampons on toxic shock syndrome toxin 1 production, Obstet. Gynecol. 64:666–670(1984).
Kirkland, J. J., and Widder, J. S., Hydrolysis of carboxymethyl-cellulose tampon material [letter], Lancet 1:1041–1042 (1983).
Tierno, P. M., Jr., and Hanna, B. A., In vitro amplification of toxic shock syndrome toxin-1 by intravaginal devices, Contraception 31:185–194 (1985).
Tierno, P. M., Jr., Hanna, B. A., and Davies, M. B., Growth of toxic-shock-syndrome strain of Staphylococcus aureus after enzymic degradation of Rely tampon component, Lancet 1:615–618(1983).
Mills, J. T., Parsonnet, J., Tsai, Y.-C., Kendrick, M., Hickman, R. K., and Kass, E. H., Control of production of toxic-shock-syndrome toxin-1 (TSST-1) by magnesium ion, J. Infect. Dis. 151:1158–1161 (1985).
Kass, E. H., Kendrick, M. I., Tsai, Y.-C., and Parsonnet, J., Interaction of magnesium ion, oxygen tension, and temperature in the production of toxic-shock-syndrome toxin-1 by Staphylococcus aureus, J. Infect. Dis. 155:812–815 (1987).
Mills, J. T., Parsonnet, J., and Kass, E. H., Production of toxic-shock-syndrome toxin-1: Effect of magnesium ion, J. Infect. Dis. 153:993–994 (1986).
Mills, J. T., Parsonnet, J., Tsai, Y.-C., Kendrick, M., Hickman, R. K., and Kass, E. H., Control of production of toxic-shock-syndrome toxin-1 (TSST-1) by magnessium ion, J. Infect. Dis. 151:1158–1161 (1985).
Schlievert, P. M., and Blomster, D. A., Production of staphylococcal pyrogenic exotoxin type C: Influence of physical and chemical factors, J. Infect. Dis. 147:236–242 (1983).
Todd, J. K., Todd, B. H., Franco-Buff, A., Smith, C. M., and Lawellin, D., Influence of focal growth conditions on the pathogenesis of toxic shock syndrome, J. Infect. Dis. 155:673–681 (1987).
Wagner, G., Bohr, L., Wagner, P., and Petersen, L. N., Tampon-induced changes in vaginal oxygen and carbon dioxide tensions, Am. J. Obstet. Gynecol. 148:147–150 (1984).
Friedrich, E. G., and Siegesmund, K. A., Tampon-associated vaginal ulcerations, Obstet. Gynecol. 55:149–156 (1980).
Fisher, C. J., Jr., Horowitz, B. Z., and Nolan, S. M., The clinical spectrum of toxic-shock syndrome, West. J. Med. 135:175–182 (1981).
Tofte, R. W., and Williams, D. N., Toxic-shock syndrome: Evidence of a broad clinical spectrum, J. Am. Med. Assoc. 246:2163–2167 (1981).
Wiesenthal, A. M., Ressman, M., Caston, S. A., and Todd, J. K., Toxic shock syndrome. I. Clinical exclusion of other syndromes by strict and screening definitions, Am. J. Epidemiol. 122:847–856 (1985).
Sperber, S. J., and Francis, J. B., Toxic shock syndrome during an influenza outbreak, J. Am. Med. Assoc. 257:1086–1087 (1987).
CDC, Toxic-Shock Syndrome—Utah, Morb. Mortal. Wkly. Rep. 29:475–476 (1980).
Helgerson, S. D., and Foster, L. R., Toxic Shock Syndrome in Oregon—epidemiologic findings, Ann. Intern. Med. 96:909–911 (1982).
Suggested Reading
Chesney, P. J., Davis, J. P., Purdy, W. K., Wand, P. J., and Chesney, K. W., Clinical manifestations of the toxic shock syndrome, J. Am. Med. Assoc. 246:741–748 (1981).
Fisher, R. F., Goodpasture, H. C., Peterie, J. D., and Voth, D. W., Toxic shock syndrome in menstruating women, Ann. Intern. Med. 94:156–163 (1981).
Proceedings of the First Interalnational Symposium on Toxic Shock syndrome, Rev. Infect. Dis. 11 (1989)
Stallones, R. A., A review of the epidemiologic studies of toxic shock syndrome, Ann. Intern. Med. 96(Part 2):917–920 (1982).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Reingold, A.L. (2009). Toxic Shock Syndrome (Staphylococcal). In: Brachman, P., Abrutyn, E. (eds) Bacterial Infections of Humans. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-09843-2_39
Download citation
DOI: https://doi.org/10.1007/978-0-387-09843-2_39
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-09842-5
Online ISBN: 978-0-387-09843-2
eBook Packages: MedicineMedicine (R0)